Cell

• 

  Año 2017, Vol. 168, Número 4. Dedicado a: Cancer, the road ahead

  • Perspective

    • Implementing genome-driven oncology

      David A. Hyman, Barry S. Taylor, Josep M. Baselga Torres

      • Resumen

      págs. 584-599

      

  • Primer

    • Applications of immunogenomics to cancer

      X. Shirley Liu, Elaine R. Mardis

      • Resumen

      págs. 600-612

      

  • Reviews

    • Clonal heterogeneity and tumor evolution: past, present, and the future

      Nicholas McGranahan, Charles Swanton

      • Resumen

      págs. 613-628

      

    • Transcriptional addiction in cancer

      James Bradner, Denes Hnisz, Richard A. Young

      • Resumen

      págs. 629-643

      

    • Endogenous DNA damage as a source of genomic instability in cancer

      Anthony Tubbs, André Nussenzweig

      • Resumen

      págs. 644-656

      

    • Understanding the intersections between metabolism and cancer biology

      Matthew Vander Heiden, R. J. DeBerardinis

      • Resumen

      págs. 657-669

      

    • Emerging biological principles of metastasis

      Arthur Lambert, Diwakar R. Pattabiraman, Robert A. Weinberg

      • Resumen

      págs. 670-691

      

    • Tumorigenic and immunosuppressive effects of endoplasmic reticulum stress in cancer

      Juan Cubillos Ruiz, Sarah E. Bettigole, Laurie H. Glimcher

      • Resumen

      págs. 692-706

      

    • Primary, adaptive and acquired resistance to cancer immunotherapy

      Padmanee Sharma, Siwen Hu-Lieskovan, Jennifer A. Wargo

      • Resumen

      págs. 707-723

      

    • The principles of engineering immune cells to treat cancer

      Carl June, Wendell A. Lim

      • Resumen

      págs. 724-740